首页 > 市场调查报告书 > 医疗设备

生技设备

多重检测市场规模、份额和成长分析（按产品类型、技术、应用、最终用户和地区划分）－2026-2033年产业预测

市场调查报告书

商品编码

1897576

多重检测市场规模、份额和成长分析（按产品类型、技术、应用、最终用户和地区划分）－2026-2033年产业预测

Multiplex Assay Market Size, Share, and Growth Analysis, By Product Type (Consumables, Instruments), By Type (Protein Multiplex Assays, Nucleic Acid Multiplex Assays), By Technology, By Application, By End-User, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月23日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格

简介目录

预计到 2024 年，多重检测市场规模将达到 40.5 亿美元，到 2025 年将达到 44.3 亿美元，到 2033 年将达到 91.7 亿美元，预测期（2026-2033 年）的复合年增长率为 9.5%。

由于慢性病和感染疾病率的上升、多重检测方法相较于传统方法的优势以及伴随诊断作用的日益增强，全球多重检测市场正经历显着增长。新型伴随诊断的核准将进一步提升市场潜力，尤其是在识别能够从标靶治疗中获益的患者方面。癌症等疾病的早期诊断至关重要，因为它可以显着提高生存率和患者的生活质量，因此在医学界日益受到重视。此外，对自动化系统和高通量检测的需求不断增长，以及生物标记检验的进步，都为市场扩张创造了机会。同时，多重检测能够分析多种生物标记物，从而简化了各个疾病领域创新诊断方法的开发。

多重检测市场驱动因素

人们对个人化医疗日益增长的兴趣是多重检测市场的主要驱动力。这些先进的检测方法能够同时评估多种生物标记物，从而提高根据患者个体反应和生物学特征进行分类的能力。这有助于制定更个人化的治疗策略，改善患者预后并优化治疗效果。随着医疗保健不断朝向个人化方向发展，多重检测将在提供精准医疗解决方案方面发挥越来越重要的作用，最终改变患者照护，并扩大这些创新诊断工具的整体市场。

限制多重检测市场发展的因素

全球多重检测市场的主要限制因素之一是检测开发和部署的复杂性和高成本。多重检测的复杂性需要先进的技术和专用设备，这可能会阻碍小规模实验室和机构采用这些先进的检测方法。此外，操作多重检测系统需要大量的培训和技术专长，这进一步加剧了市场复杂性。这些因素可能会限制其普及性并增加营运成本，最终阻碍潜在用户的采用率并减缓市场成长。此外，与检验和核准流程相关的监管障碍也可能带来额外的挑战。

多重检测市场趋势

多重检测市场正经历显着的成长趋势，这主要得益于多重免疫检测技术的日益普及。该技术能够同时检测单一检体中的多种蛋白质，从而显着提升药物研发、诊断检测和生物标记鑑定流程的效率，满足了医疗保健和研究领域对快速、全面分析日益增长的需求。此外，检测技术的进步和自动化技术的整合也进一步推动了市场成长。随着研究人员和临床医生对高性价比、高通量解决方案的需求不断增长，预计对多重检测的需求将持续攀升，巩固其作为现代分析方法中不可或缺的工具的地位。

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争资讯

前五大公司对比
主要企业的市场定位（2025 年）
主要市场参与者所采取的策略
近期市场趋势
公司市占率分析（2025 年）
主要企业公司简介
- 公司详情
- 产品系列分析
- 依业务板块进行公司股票分析
- 2023-2025年营收年比比较

主要企业简介

Lonza Group（Switzerland）
DiaSorin（Italy）
WuXi Biologics（China）
Seegene（South Korea）
Ayoxxa Biosystems（Germany）
Thermo Fisher Scientific（United States）
Bio-Rad Laboratories（United States）
Luminex Corporation（United States）
QIAGEN（Germany）
Illumina（United States）
Agilent Technologies（United States）
PerkinElmer（United States）
Merck KGaA（Germany）
Becton, Dickinson and Company（United States）
Roche Diagnostics（Switzerland）
Siemens Healthineers（Germany）
Danaher Corporation（United States）
Abbott Laboratories（United States）
Meso Scale Diagnostics（United States）
Quanterix Corporation（United States）

结论与建议

简介目录

Product Code: SQMIG35H2180

Multiplex Assay Market size was valued at USD 4.05 Billion in 2024 and is poised to grow from USD 4.43 Billion in 2025 to USD 9.17 Billion by 2033, growing at a CAGR of 9.5% during the forecast period (2026-2033).

The global multiplex assay market is experiencing significant growth driven by the increasing prevalence of chronic and infectious diseases, the advantages of multiplex assays over traditional methods, and their expanding role in companion diagnostics. The approval of new companion diagnostics is expected to further enhance market potential, particularly in identifying patients who would benefit from targeted therapies. Early diagnosis of diseases like cancer is crucial, as it can significantly improve survival rates and patient quality of life, leading to heightened awareness in the healthcare sector. Moreover, the rising demand for automated systems and high-throughput assays, along with the validation of biomarkers, amplifies opportunities for market expansion. Furthermore, multiplex assays facilitate extensive biomarker analysis, streamlining the development of innovative diagnostics in various disease areas.

Top-down and bottom-up approaches were used to estimate and validate the size of the Multiplex Assay market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Multiplex Assay Market Segments Analysis

Global Multiplex Assay Market is segmented by Product Type, Type, Technology, Application, End-User and region. Based on Product Type, the market is segmented into Consumables, Instruments and Software. Based on Type, the market is segmented into Protein Multiplex Assays, Nucleic Acid Multiplex Assays and Cell-based Multiplex Assays. Based on Technology, the market is segmented into Flow Cytometry, Fluorescence Detection, Luminescence, Multiplex Real-time PCR and Others. Based on Application, the market is segmented into Research & Development and Clinical Diagnostics. Based on End-User, the market is segmented into Pharmaceutical & Biotechnology Companies, Hospitals & Research Institutes, Reference Laboratories and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Multiplex Assay Market

The increasing interest in personalized medicine is significantly propelling the multiplex assay market. These advanced assays facilitate the concurrent assessment of multiple biomarkers, which enhances the ability to classify patients based on their individual responses and biological characteristics. Consequently, this capability leads to more tailored treatment strategies, improving patient outcomes and optimizing therapeutic efficacy. As healthcare continues to evolve towards more individualized approaches, the role of multiplex assays becomes increasingly vital in delivering precision medicine solutions, ultimately transforming patient care and boosting the overall market for these innovative diagnostic tools.

Restraints in the Multiplex Assay Market

One key market restraint for the global multiplex assay market is the complexity and high cost associated with assay development and implementation. The intricate nature of multiplex assays, which require sophisticated technologies and specialized equipment, can deter smaller laboratories or facilities from adopting these advanced testing methods. Additionally, the need for extensive training and technical expertise to operate multiplex assay systems further complicates the market landscape. These factors can limit accessibility and increase operational expenses, ultimately hindering adoption rates among potential users and slowing market growth. Furthermore, regulatory hurdles related to validation and approval processes can introduce additional challenges.

Market Trends of the Multiplex Assay Market

The multiplex assay market is witnessing a notable trend driven by the growing adoption of multiplex immunoassays, which enable the simultaneous measurement of multiple proteins from a single sample. This capability significantly enhances efficiency in drug discovery, diagnostic testing, and biomarker identification processes, catering to the rising need for rapid and comprehensive analysis in healthcare and research. Additionally, advancements in assay technologies and the integration of automation are further propelling market growth. As researchers and clinicians increasingly seek cost-effective, high-throughput solutions, the demand for multiplex assays is expected to expand, solidifying their role as essential tools in modern analytical practices.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Landscape
Case Studies
Technological Advancement

Global Multiplex Assay Market Size by Product Type & CAGR (2026-2033)

Market Overview
Consumables
Instruments
Software

Global Multiplex Assay Market Size by Type & CAGR (2026-2033)

Market Overview
Protein Multiplex Assays
- Planar Protein Assays
- Bead-based Protein Assays
- Others
Nucleic Acid Multiplex Assays
- Planar Nucleic Acid Assays
- Bead-based Nucleic Acid Assays
- Others
Cell-based Multiplex Assays

Global Multiplex Assay Market Size by Technology & CAGR (2026-2033)

Market Overview
Flow Cytometry
Fluorescence Detection
Luminescence
Multiplex Real-time PCR
Others

Global Multiplex Assay Market Size by Application & CAGR (2026-2033)

Market Overview
Research & Development
- Drug Discovery & Development
- Biomarker Discovery & Validation
Clinical Diagnostics
- Infectious Diseases
- Cancer
- Cardiovascular Diseases
- Autoimmune Diseases
- Nervous System Disorders
- Metabolism & Endocrinology Disorders
- Other Diseases

Global Multiplex Assay Market Size by End-User & CAGR (2026-2033)

Market Overview
Pharmaceutical & Biotechnology Companies
Hospitals & Research Institutes
Reference Laboratories
Others

Global Multiplex Assay Market Size & CAGR (2026-2033)

North America (Product Type, Type, Technology, Application, End-User)
- US
- Canada
Europe (Product Type, Type, Technology, Application, End-User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product Type, Type, Technology, Application, End-User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product Type, Type, Technology, Application, End-User)
- Brazil
- Rest of Latin America
Middle East & Africa (Product Type, Type, Technology, Application, End-User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Lonza Group (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
DiaSorin (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
WuXi Biologics (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Seegene (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ayoxxa Biosystems (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Luminex Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
QIAGEN (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Illumina (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PerkinElmer (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Roche Diagnostics (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Meso Scale Diagnostics (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Quanterix Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments